Thomas Kosasa Purchases 158,730 Shares of OneMedNet (NASDAQ:ONMD) Stock

OneMedNet Corporation (NASDAQ:ONMD) Director Thomas Kosasa bought 158,730 shares of OneMedNet stock in a transaction that occurred on Friday, June 12th. The shares were acquired at an average price of $0.63 per share, with a total value of $99,999.90. Following the acquisition, the director directly owned 17,088,874 shares of the company’s stock, valued at $10,765,990.62. The trade was a 0.94% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Thomas Kosasa also recently made the following trade(s):

• On Monday, May 18th, Thomas Kosasa bought 268,817 shares of OneMedNet stock. The shares were acquired at an average price of $0.93 per share, with a total value of $249,999.81.
• On Thursday, April 23rd, Thomas Kosasa bought 280,898 shares of OneMedNet stock. The shares were acquired at an average price of $0.89 per share, with a total value of $249,999.22.

OneMedNet Trading Down 10.2%

Shares of ONMD opened at $0.50 on Wednesday. The stock has a market capitalization of $27.27 million, a price-to-earnings ratio of -10.02 and a beta of 1.12. The firm has a fifty day simple moving average of $0.86 and a 200 day simple moving average of $0.95. OneMedNet Corporation has a 12 month low of $0.33 and a 12 month high of $4.22.

OneMedNet (NASDAQ:ONMD) last released its quarterly earnings data on Friday, May 15th. The company reported ($0.04) earnings per share for the quarter. The firm had revenue of $0.10 million for the quarter.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Wall Street Zen cut shares of OneMedNet from a “hold” rating to a “sell” rating in a report on Saturday, May 23rd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of OneMedNet in a report on Monday, June 1st. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has a consensus rating of “Sell”.

Institutional Trading of OneMedNet

Hedge funds have recently modified their holdings of the stock. HRT Financial LP acquired a new stake in shares of OneMedNet during the 4th quarter worth about $32,000. Virtu Financial LLC acquired a new stake in shares of OneMedNet during the 4th quarter worth about $48,000. Jane Street Group LLC acquired a new stake in shares of OneMedNet during the 4th quarter worth about $119,000. State Street Corp increased its stake in shares of OneMedNet by 41.5% during the fourth quarter. State Street Corp now owns 116,700 shares of the company’s stock worth $128,000 after purchasing an additional 34,200 shares during the period. Finally, Exencial Wealth Advisors LLC increased its stake in shares of OneMedNet by 1.3% during the fourth quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock worth $4,009,000 after purchasing an additional 45,401 shares during the period. Institutional investors and hedge funds own 0.95% of the company’s stock.

About OneMedNet

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.